IOR study reveals how breast cancer therapy may be effective against COVID-19

The so-called “Selective Estrogen Receptor Modulators (SERMs)” treatments used in breast cancer therapy may be effective against COVID-19. A study conducted by the Institute of Oncology Research (IOR, affiliated to USI) based on data obtained from the Veneto Tumor Registry (Italy) has observed a lower risk of developing the coronavirus disease for women affected by hormonal-driven cancers subjected to this type of therapy. The study, performed in collaboration with the VIMM-University of P...
More